Evidence map›Paper›PMID 37071670›Full record

ArticleThe CRISPR journal2023

Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic.

Arijit Panda, Milovan Suvakov, Jessica Mariani, Kristen L Drucker, Yohan Park, Yeongjun Jang, Thomas M Kollmeyer, Gobinda Sarkar, Taejeong Bae, Jean J Kim and 4 more

Erratum issuedAbstract read
In one paragraph

Article in The CRISPR journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The modern human aryl hydrocarbon receptor is more active when ancestralized by genome editing.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Arijit PandaDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-5156-6459
Milovan SuvakovDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jessica MarianiChild Study Center, Yale University, New Haven, Connecticut, USA.
Kristen L DruckerDepartment of Lab Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Yohan ParkAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Yeongjun JangDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Thomas M KollmeyerDepartment of Lab Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Gobinda SarkarDepartment of Lab Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Taejeong BaeDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jean J KimDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
Wan Hee YoonAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Robert B JenkinsDepartment of Lab Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Flora M VaccarinoChild Study Center, Yale University, New Haven, Connecticut, USA.
Alexej AbyzovDepartment of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Neurodevelopment of Tourette syndromeR01MH118453 · NIMH · YALE UNIVERSITY · PI FLORA M VACCARINO · 2019 to 2026
$4.0M
UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMASR01CA230712 · NCI · MAYO CLINIC ROCHESTER · PI JENKINS, ROBERT B. · 2018 to 2022
$3.3M
Neurobiology of Autism With MacrocephalyR01MH109648 · NIMH · YALE UNIVERSITY · PI VACCARINO, FLORA M · 2016 to 2021
$3.3M
Detection of somatic, subclonal and mosaic CNVs from sequencingU24CA220242 · NCI · MAYO CLINIC ROCHESTER · PI ABYZOV, ALEXEJ · 2018 to 2022
$2.6M
Role of ATAD3A in Lysosomal Homeostasis and NeurogenesisR01NS121298 · NINDS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI YOON, WAN HEE · 2021 to 2025
$2.2M
Engineering of organoid-based brain circuitsRF1MH123978 · NIMH · YALE UNIVERSITY · PI LEVCHENKO, ANDRE, VACCARINO, FLORA M · 2020 to 2020
$1.6M
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA230712NCI NIH HHS U24 CA220242NIMH NIH HHS R01 MH109648NIMH NIH HHS R01 MH118453NIMH NIH HHS RF1 MH123978NINDS NIH HHS R01 NS121298
6 · The paper itself

Abstract

The CRISPR-Cas9 system has enabled researchers to precisely modify/edit the sequence of a genome. A typical editing experiment consists of two steps: (1) editing cultured cells; (2) cell cloning and selection of clones with and without intended edit, presumed to be isogenic. The application of CRISPR-Cas9 system may result in off-target edits, whereas cloning will reveal culture-acquired mutations. We analyzed the extent of the former and the latter by whole genome sequencing in three experiments involving separate genomic loci and conducted by three independent laboratories. In all experiments we hardly found any off-target edits, whereas detecting hundreds to thousands of single nucleotide mutations unique to each clone after relatively short culture of 10-20 passages. Notably, clones also differed in copy number alterations (CNAs) that were several kb to several mb in size and represented the largest source of genomic divergence among clones. We suggest that screening of clones for mutations and CNAs acquired in culture is a necessary step to allow correct interpretation of DNA editing experiments. Furthermore, since culture associated mutations are inevitable, we propose that experiments involving derivation of clonal lines should compare a mix of multiple unedited lines and a mix of multiple edited lines.

Indexed as

CRISPR-Cas SystemsGene EditingDNAMutationDNA

Identifiers

PMID37071670
PMCPMC10123805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.